Siemens AG Reviewing Stake in Siemens Healthineers

MUNICH (Reuters) – Siemens AG (OTC:SIEGY) is reviewing its majority stake in medical technology subsidiary Siemens (ETR:SIEGn) Healthineers, according to Chief Financial Officer Ralf Thomas, as reported by Handelsblatt.

The synergies with the MRI machine and laboratory systems manufacturer are insufficient to justify a capital commitment of €45 billion ($46.91 billion), according to Thomas, referencing the value of Siemens' 75% equity stake.

> "We are evaluating the economic opportunities for Siemens AG in the healthcare sector. We will then derive from this how instrumental Healthineers is as an investment. And then we will draw a conclusion from that," he shared, noting that results will be presented at a capital markets day at the end of 2025.

Siemens AG had spun off the Erlangen, Germany-based subsidiary in 2018 and listed it on the stock exchange. Previously, Siemens had indicated its intention to retain its majority stake in Siemens Healthineers.

However, Thomas recently suggested the possibility of selling around 5% in the foreseeable future to finance the acquisition of the U.S. software company Altair.

Thomas also emphasized his commitment to the Mobility train division, responding to investor calls for a spin-off.

> "The business is in good hands with us. I don't see any need for us to part with it at the moment," he confirmed to Handelsblatt.

> ($1 = 0.9592 euros)